Alentis Therapeutics
Series ABasel, SwitzerlandApr 2019
Alentis Therapeutics raised €11M in a Series A round in Apr 2019. The company is based in Basel, Switzerland. Investors in the round: BioMedPartners, Pureos Bioventures. Data as of Nov 2026.
Amount raised
€11M
€11,179,680
Native amount
12,500,000 CHF
Stage
Series A
series a
Investors
2
Provenance & confidence
High confidenceAmount
12,500,000 CHF
ECB-at-date → €11M · rate 1.1181 on 2019-03-29
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
2 namedDate
Apr 2019
Round type
series a
Amount (EUR)
€11M
Other rounds
same companyThis is the company's only recorded round.